85%Confidence
0Views
FDASource
2026-04-08Date
Summary
Strides Pharma's Class II recall for Children's Ibuprofen due to foreign particles indicates serious manufacturing contamination issues that could significantly damage brand trust. This recall, affecting a pediatric product, may lead to consumer preference shifts toward competing brands.
Actionable: Monitor consumer sentiment and market share changes in the pediatric pain relief segment following this recall.
AI Confidence: 85%
Data Points
firmSTRIDES PHARMA INC
classificationClass II
statusOngoing
distributionU.S.A. Nationwide
productChildren's Ibuprofen Oral Suspension, USP, 100 mg per 5mL, 4 FL OZ (120 mL) bottle, Manufactured for: Taro Pharmaceuticals U.S.A., Inc., Hawthorne, NY
Get Signals Instantly
Premium subscribers receive every signal via Telegram the moment it fires — hours before it appears here.
Subscribe Now